We report the first laboratory-confirmed case of Rickettsia mongolotimonae infection in Africa. The patient sought treatment for an eschar on his toe; lymphangitis, severe headaches, and fever subsequently developed. After a regimen of doxycycline, symptoms rapidly resolved. R. mongolotimonae infection was diagnosed retrospectively by serologic tests and molecular-based detection of the organism in biopsy specimens of eschar material. R ickettsioses are infections of emerging medical importance, particularly in southern Africa, where an increasing number of cases are being encountered among both residents and tourists (1). Three Rickettsia species have been associated with human disease in South Africa to date. Rickettsia conorii has long been recognized as the agent of Mediterranean spotted fever, and more recently, a newly recognized species, R. africae, has been identified as the agent of African tick-bite fever. In 2002, the first case report of a patient infected with R. aeschlimannii was published (2). In addition to these recognized pathogens, Rickettsia species, including R. mongolotimonae, have been detected in human-biting arthropods in Africa. This species (3) was first encountered in Hyalomma asiaticum ticks in Inner Mongolia in 1991 (4) but has subsequently been associated with human infections in southern France (5) and, perhaps of most relevance to this report, has been detected in H. truncatum ticks collected from cattle in Niger (6). This species of tick, which at least during its immature life stages parasitizes migratory birds, is widely distributed in many African countries, including South Africa (7).
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The Study
In September 2002, a 34-year-old (HIV-seronegative) construction worker, working near Ellisras in South Africa's Northern Province, discovered a lesion on the inside of the second toe on his right foot (Figure) ; subsequently, severe headaches and high fever developed. He was examined at a local hospital and found to have lymphangitis extending pretibially from the lesion; as a result of his other symptoms, he was treated for blood poisoning with ceftriaxone sodium, 1,000 mg once daily. During the next 3 days, the lesion at the bite site (noted by the examining physician) remained very sore, and the patient's right inguinal lymph node became enlarged and very painful. The patient then decided to return to his hometown and sought treatment from his general practitioner (on day 5 after discovery of the lesion). On examination, the lesion and lymphangitis were clearly visible on the patient's toe, although cellulitis and edema were not observed. His inguinal lymph node had swollen to 3 cm in diameter, and he was still febrile (38.5°C). Blood samples were then obtained as well as a biopsy specimen from the lesion. A regimen of doxycycline, 100 mg per day orally, for 5 days was prescribed and 1 day's dosage was administered. The next day, the patient was afebrile, and the lymphangitis had completely resolved.
In the laboratory, a Giemsa stain of a smear prepared from the patient's blood showed activated lymphocytes. A complete blood count showed thrombocytosis (632 x 10 3 /µL), but all other hematologic parameters were within the normal range. Biochemical findings showed elevated levels of alanine transaminase (66 IU/L), blood urea nitrogen 64 were found by using both antigens. DNA was extracted from the eschar biopsy specimen by using the QIAamp Tissue kit (QIAGEN GmbH, Hilden, Germany) according to the manufacturer's instructions. This DNA extract was used as template in a previously described polymerase chain reaction assay targeting a Rickettsia spp. rOmpA fragment (9) . An amplification product was obtained from this extract but not from any concurrently processed control materials. The amplification product was purified; the nucleic acid sequences of both strands were then determined. The sequence obtained from these efforts was found to share >99% similarity with the corresponding rOmpA fragment of R. mongolotimonae.
Conclusions
The combination of clinical and laboratory data yielded strong evidence that the case described here was an infection of R. mongolotimonae, the first reported in southern Africa. A single eschar is also typical of R. conorii infections, but these are characterized by rash (Mediterranean spotted fever), which the current patient did not have. Although R. africae infections manifest only rarely as a rash, they are typified by multiple eschars (10) . This case description is also very similar to that relating to a French patient infected with R. mongolotimonae, who had lymphangitis and inguinal lymphadenopathy. The serologic findings indicate exposure to a spotted fever group rickettsia rather than to a specific species within this group, but the near identity of the rOmpA sequence obtained from the patient's eschar to that of R. mongolotimonae provides a clear indication that this species, rather than other spotted fever group rickettsiae, was present at the site of the tick bite. Although no tick was found in association with the patient's eschar, his infection may have been acquired from a H. truncatum, as this species is abundant in the region of the bushveld where the patient had been working and is known to feed on humans (11) .
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